Clinical Trial Update: Copeptin: Disease Severity Indicator [NA]

View source ↗

Summary

A completed clinical trial evaluated copeptin as a biomarker for disease severity in patients with lower respiratory tract infections, including bronchitis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Bronchopneumonia
• Lower Respiratory Tract Infection
• Ventilator-associated Pneumonia

Snippet

Sponsor: Berker Okay | Conditions: Lower Respiratory Tract and Lung Infections, Ventilator Lung | NA | Status: COMPLETED